Zusammenfassung
Sportler und insbesondere Leistungssportler sind meist junge Menschen, mit denen kein erhöhtes Gesundheitsrisiko, es sei denn für Traumata, assoziiert wird. Es kommt aber signifikant häufiger zu Fällen des plötzlichen Herztodes (PHT) in dieser Gruppe. Die Inzidenz des PTH bei Sportlern bewegt sich zwischen 0,6 und 3,0/100.000 pro Jahr. Häufig ist der PHT hier das erste Erscheinungsbild einer zugrunde liegenden kardialen Grunderkrankung. Dazu gehören strukturelle Erkrankungen wie hypertrophe Kardiomyopathie, Koronaranomalien, Myokarditis, koronare Herzerkrankung und arrhythmogene rechtsventrikuläre Kardiomyopathie, aber auch Erkrankungen ohne strukturelle Herzveränderungen wie Ionenkanalerkrankungen. Durch ein einfaches Screening können viele dieser Erkrankungen erkannt und Behandlungen oder Vorsichtsmaßnahmen eingeleitet werden.
Abstract
Athletes and especially elite athletes are predominantly young people and are not associated with high health risks, apart from traumatic injuries. Nevertheless, there is a significantly high incidence of sudden cardiac death (SCD), which ranges from 0.6 to 3.0/100,000 athletes per year. Often the SCD is the first manifestation of an underlying cardiac disease. Distinct structural cardiac disorders, such as hypertrophic cardiomyopathy, coronary artery anomalies (17 %), inflammatory disorders (6 %) and arrhythmogenic right ventricular cardiomyopathy as well as conditions without structural cardiac abnormalities, such as primary electrical diseases (channelopathies) are important causes of sudden death. A simple screening can help to identify athletes with these diseases and allow specific therapies or precautionary measures to be initiated.
Literatur
Thompson PD, Franklin BA, Balady GJ et al; American Heart Association Council on Nutrition, Physical Activity, and Metabolism, American Heart Association Council on Clinical Cardiology, American College of Sports Medicine (2007) Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 115:2358–2368
Corrado D, Basso C, Pavei A et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening programme. JAMA 296:1593–1601
Albert CM, Mittleman MA, Chae CU et al (2000) Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343:1355–1361
Thompson PD, Funk EJ, Carleton RA et al (1982) Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 247:2535–2538
Maron BJ, Doerer JJ, Haas TS et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119:1085–1092
Corrado D, Basso C, Rizzoli G et al (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963
Marijon E, Tafflet M, Celermajer DS et al (2011) Sports-related sudden death in the general population. Circulation 124:672–681
Kim JH, Malhotra R, Chiampas G et al; Race Associated Cardiac Arrest Event Registry (RACER) Study Group (2012) Cardiac arrest during long-distance running races. N Engl J Med 366:130–140
Corrado D, Schmied C, Basso C et al (2011) Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 32:934–944
Elliot PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218
Cheitlin MD, MacGregor J (2009) Congenital anomalies of coronary arteries. Herz 34:268–279
Maron BJ (2003) Sudden death in young athletes. N Engl J Med 349:1064–1075
Basso C, Corrado D, Bauce B, Thiene G (2012) Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 5:1233–1246
Maisch B, Pankuweit S (2013) Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev 18:761–795
Maisch B, Ruppert V, Pankuweit S (2014) Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options. Curr Heart Fail Rep 11:166–177
Chimenti C, Pieroni M, Frustaci A et al (2006) Myocarditis: when to suspect and how to diagnose it in athletes. J Cardiovasc Med 7:301–306
Heidbuchel H, Corrado D, Biffi A et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 13:676–686
Viskin S, Wilde AAM, Guevara-Valdivia ME (2013) Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol 61:2383–2387
Di Paolo FM, Schmied C, Zerguini YA et al (2012) The athlete’s heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol 59:1029–1036
Corrado D, Pelliccia A, Heidbuchel H et al (2010) Recommendations for interpretation of 12-lead electrocardiogram in the athlete. EHJ 31:243–259
Schimpf R, Veltmann C, Wolpert C et al (2009) Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT. Herz 34:281–288
Maron BJ, Thompson PD, Puffer JC et al (2007) Cardiovascular preparticipation screening of competitive athletes. A statement from the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Disease in the Young), American Heart Association. Circulation 115:1–13
Corrado D, Pelliccia A, Bjornstad HH et al (2005) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial diseases of the European Society of Cardiology. Eur Heart J 26:516–524
Ljungqvist A, Jenoure P, Engebretsen L et al (2009) The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 43:631–643
Maron BJ, Zipes DP (2005) 36th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 45:1373–1375
Baggish AL, Hutter AM Jr, Wang F et al (2010) Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 152:269–275
Ryan MP, Cleland JG, French JA et al (1995) The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 76:689–694
Corrado D, Basso C, Schiavon M et al (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339:364–369
Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 92:785–789
Pelliccia A, Di Paolo FM, Corrado D et al (2006) Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 27:2196–2200
Einhaltung ethischer Richtlinien
Interessenkonflikt. T. Tönnis, C. Tack und K.-H. Kuck geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tönnis, T., Tack, C. & Kuck, KH. Plötzlicher Herztod bei Sportlern und dessen Prävention. Herz 40, 379–385 (2015). https://doi.org/10.1007/s00059-015-4225-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-015-4225-3